The complex link between respiratory dysfunction and psychiatric disorders

Respiratory diseases are significant global health concerns, contributing to substantial morbidity and mortality. Chronic obstructive pulmonary disease (COPD), asthma, and obstructive sleep apnea (OSA) are associated with chronic inflammation and hypoxia, often leading to reduced quality of life, frequent exacerbations, and long-term disability. Respiratory dysfunction exacerbates psychiatric conditions, and mental health disorders can worsen respiratory symptoms, creating a bidirectional interaction. This complex relationship is associated with increased mortality, exacerbation rates, and hospital admissions and can negatively influence the patient's quality of life and prognosis. Despite the profound impact of both conditions, the interaction between respiratory and psychiatric diseases is often overlooked, failing to capture their intricate nature. Hypoxia is a primary pathophysiological mechanism that triggers a cascade of systemic effects, including increased oxidative stress and inflammation. In addition, the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which controls the stress response, plays a significant role in the interaction between respiratory dysfunction and psychiatric disorders. The overlap of symptoms between depression, anxiety, mood disorders, and respiratory diseases complicates the diagnosis, but the use of different questionnaires as screening tools can facilitate early detection, improving the management of these patients. A multidisciplinary clinical approach includes cognitive behavioral therapy, pulmonary rehabilitation programs, and pharmacological therapy, the latter after thoroughly evaluating the potential risks and benefits. Future studies and treatments must focus on early intervention methods and support patients in a way that reflects the complexity of the relationship between respiratory and mental health.